Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HNGE
Strong BuyPremium GrowerFLAGHinge Health, Inc. · Healthcare · United States · $7.0B · Avg Vol: $167M/d
Hinge Health has the strongest momentum in this batch at M92 with a buyback retiring 4.49% of shares, but value at V30 is well below the calibrated floor. Insiders sold 6.81% of shares outstanding, the largest disposal in this batch, which is decisively adverse.
COMPANY DESCRIPTION
Hinge Health, Inc. is a leading digital healthcare company specializing in musculoskeletal (MSK) care, offering virtual physical therapy and clinical coaching. The company holds a dominant market position in the digital MSK space, serving a vast portfolio of enterprise employers and health plans to reduce medical spend. It utilizes a proprietary platform combining wearable sensors, computer vision, and dedicated clinical teams to deliver personalized, home-based care.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 292.7M | 390.4M | 587.9M | 41.7% | 720.1M | 859.3M | 1.1B | 36.0% |
| EPS | -1.58 | -0.15 | -7.77 | — | 8.22 | — | — | — |
| Shares | 78.0M | 78.0M | 79.2M | +1.5% | 62.5M | — | — | — |
| Debt | 15.7M | 11.1M | 8.0M | -28.5% | 5.9M | — | — | — |
| Equity | 427.3M | 416.7M | 378.5M | -5.9% | — | — | — | — |
| Op CF | -63.9M | 49.0M | 171.4M | 249.9% | 290.8M | — | — | — |
| Inv CF | 1.5M | 18.3M | -113.8M | — | — | — | — | — |
| Fin CF | -3.0M | -2.2M | -150.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HNGE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HNGE | Hinge Health, Inc.(you) | $7.0B | 84 | Strong Buy |
| HQY | HealthEquity, Inc. | $8.0B | 82 | Strong Buy |
| BTSG | BrightSpring Health Services, Inc. | $11.7B | 84 | Strong Buy |
| TXG | 10x Genomics, Inc. | $8.0B | 60 | Hold |
| WAY | Waystar Holding Corp. | $5.0B | 62 | Hold |
| DOCS | Doximity, Inc. | $4.8B | 61 | Hold |
| VEEV | Veeva Systems Inc. | $44.8B | 82 | Strong Buy |
| GDRX | GoodRx Holdings, Inc. | $1.2B | 77 | Buy |
| HSTM | HealthStream, Inc. | $859M | 87 | Strong Buy |
| OMCL | Omnicell, Inc. | $1.5B | 66 | Buy |
Peer medians: ROE -30.8% · P/E 27.1x · Gross margin 58.1%